EquityZen Growth Technology Fund LLC - Series 1323
Raised
$304K
Investors
17
Min Invest
$10,010
AltStreet Analysis
·Generated from EDGAR primary sources
EquityZen Growth Technology Fund LLC - Series 1323 is a Delaware-based pooled investment fund that raised $304K from 17 investors with a $10K minimum investment under Rule 506(b) and 3(c)(1) exemptions. This amended filing was submitted July 8, 2022, and is part of the EquityZen platform, which operates over 1,800 pre-IPO access vehicles. EquityZen Advisors and Assure Fund Management II serve as executive officers and directors.
This pre-IPO fund follows the standard EquityZen series structure: a sub-$1M raise with low minimum investment ($10K) using the 506(b) private placement exemption paired with 3(c)(1) to remain outside Investment Company Act registration. The investor count (17) and average check size (~$18K) are typical for retail-accessible pre-IPO participation vehicles in this category.
Data Flags
EDGAR Filing Data
Form D — Primary Source
View on SEC.govRelated Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
EquityZen Advisors LLC
Executive Officer, Director · New York, NY
Richard Thoms
Executive Officer · Salt Lake City, UT
Assure Fund Management II LLC
Director · Salt Lake City, UT
Philip Haslett
Executive Officer, Director · New York, NY
Is this your offering?
Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.
